Softimize Ltd. (BioT)

www.biot-med.com

High-Tech Company

TECH VERTICALS

Cloud, Cyber Security, Digital Health, Healthcare IT, Healthtech, Infrastructure, IoT, Life Sciences, MedTech, Remote Monitoring, Sensors, Wearables, Wellness

General Data

Sector	Digital Health
Company Stage:	Initial Revenues
Established	2018
Number of Employees	35
Reg. Number:	abCDe

DESCRIPTION

BioT is the infrastructure for medical device clouds - the secure, simple, and smart foundation for delivering next-generation care. With native, medical-grade security and compliance, BioT ensures medical data stays safe and private from day one. Its flexible developer studio makes adding new services and capabilities quick and easy. And connecting the users cloud to EHRs, 3rd party algorithms, or any external system comes naturally. With BioT, the user has the infrastructure needed to build the users cloud right and provide more impactful care from the start.

TECHNOLOGY

BioT offers PaaS infrastructure for medical device clouds that meets HIPAA / FDA cybersecurity / HITRUST regulatory challenges ("medical device" includes SaMD - Software as Medical Device).
BioT infrastructure focuses on data analytics and operational capabilities and addresses a range of requirements, beginning with clinical studies (e.g., safety and efficacy dashboards), and extending to comprehensive enterprise needs like vulnerability monitoring, patient monitoring, video consultations, and more.
The platform is highly flexible - it is configurable through NoCode and supports custom code deployments. It is validated for monitoring, diagnostics, or therapeutics intended uses, and for any care setting - from hospital, to point of care, to home.
The platform is designed for class III regulatory compliance in the US & EU and holds advanced certificates such as SOC II Type 2.
Using BioT drastically reduces cyber risks, regulatory risks, and AI innovation risks.

Products and Phases

Product	Phase
BioT platform	FDA Approved
The infrastructure for medical device clouds - the flexible, open, and secure foundation needed to build the users cloud right and deliver more impactful care from the start.

ESTIMATED ANNUAL SALES

	TARGET MARKETS
	Medical device manufacturers, Pharmaceutical companies, Wellness/Fitness companies

	BUSINESS MODEL
	B2B

COMPETITORS

BrightInsight , Galen Data

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Law Firm
abC Defghij	Patent Attorneys
abC Defghij	Accounting Firm
abC Defghij	Investment Bank

CONTACT INFO

Expand / Collapse All

Main Address: Petach Tikva, Israel

Address	2 Granit St.
City	Petach Tikva
Country	Israel
Zip	4951446

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Boston, United States

Address	1313 Washington St. Suite #229
City	Boston
State/Province	MA
Country	United States
Zip	02118

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Daniel Adler	CEO & Co-Founder	Digital Clues (VP, Sales & Business Development)
Mr. Guy Vinograd	CTO & Co-Founder
Mr. Boaz Vaizler	COO & Co-Founder
Mr. Itai Weissman	VP, Products	Allot (VP, Product Management)
Mr. Hanan Drobiner	Global Business Development Director
Mr. David Ronen	Co-Founder	ECtel (SVP, Marketing & Strategy)

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	General Partner, North First Ventures
abC Defghij	Board Member	Managing Partner, Bridges Israel
abC Defghij	Board Member	Managing Director, Fosun RZ
abC Defghij	Observer	Co-Founder, bio-T
abC Defghij	Board Member	Managing Director, XT Hi-Tech Investments

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed

Jul. 01, 2023

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Investment Company	abCDe

Seed - Extended

Oct. 01, 2022

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Investment Company	abCDe

Seed - Extended

Jun. 29, 2021

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe	Led the round
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Seed - Extended

Jun. 01, 2021

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Investment Company	abCDe

Seed

May. 03, 2020

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe	Led the round
abC Defghij	Private Investor	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2024

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Mar. 01, 2023

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2020

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Dec. 01, 2019

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Bi-Lateral R&D Program	abCDe

	Non-Equity Assistance

Expand / Collapse All

Date

Stage

Remarks

Non-Equity Assistance

Dec. 05, 2023

Initial Revenues

Contributor	Type	Amount	Remarks
abC Defghij	Corporate Accelerator	abCDe

Non-Equity Assistance

Jul. 01, 2022

Initial Revenues

Contributor	Type	Amount	Remarks
abC Defghij	Corporate Accelerator	abCDe

Non-Equity Assistance

May. 13, 2020

Initial Revenues

Contributor	Type	Amount	Remarks
abC Defghij	General Accelerator	abCDe

Last Updated:	abCDe
IVC Number:	abCDe